Frontier Medicines
Frontier Medicines is a biotech company developing precision medicines for previously undruggable disease-causing proteins, with a lead program targeting KRAS G12C in cancers. The company has raised $256M, most recently in a Series C round in June 2024, and employs 78 people.
The growth story
Frontier Medicines grew from 64 to 78 employees between 2021 and 2026, raising $256M along the way, most recently a Series C in June 2024.
About
Frontier Medicines develops drugs targeting proteins that were previously considered undruggable, using chemoproteomics, covalent drug discovery, and machine learning. Its lead program focuses on KRAS G12C, a cancer driver protein.
The company has raised $256M across funding rounds, including a Series C in June 2024. It employs 78 people, with a median tenure of 2 years, suggesting rapid team growth or turnover.
Founders and leadership
Research is the largest function at Frontier Medicines, with 21 employees. The company operates from dual headquarters in South San Francisco and Boston.
The Frontier Medicines org chart
Chris Varma (Co-Founder, Chairman & CEO) leads 31 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 30 (-9% YoY), Business Development 16 (+14% YoY), Healthcare Services 5 (0% YoY), Information Technology 4 (-33% YoY), Administrative 3 (+50% YoY).
Talent flow
Frontier Medicines recruits heavily from major pharma companies, with Novartis, Broad Institute, and Pfizer each contributing 4 hires. Alumni most often move to Eli Lilly, Septerna, and Nurix Therapeutics.
Most common previous employers of Frontier Medicines staff: Novartis (4), Broad Institute of MIT and Harvard (4), Pfizer (4), Genentech (3), Bristol Myers Squibb (3), Thermo Fisher Scientific (3). Former Frontier Medicines employees most often moved to Eli Lilly and Company (4), Septerna (3), Nurix Therapeutics (3), Gilead Sciences (3), Magnet Biomedicine (2), - (2).
Alumni worth knowing
Hiring now
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Frontier Medicines: Drug Discovery (29), Molecular Biology (21), Biotechnology (20), Oncology (19), Research Skills (17), Life Sciences (17), Organic Synthesis (16), Cell Culture (15).
Where the team actually sits
Frontier Medicines people are concentrated in Massachusetts, United States (21), California, United States (19), Greater Boston (11), United States (4).
Search footprint
Frontier Medicines attracts about 195 organic search visits a month, traffic worth roughly $9K a month if bought through ads. It gained 58 ranking keywords and lost 59 in the last period.
What employees say
- Compensation
- 4.10 / 5
- Career opportunities
- 3.90 / 5
- Senior management
- 3.90 / 5
- Work-life balance
- 4.30 / 5
Frequently asked
Frontier Medicines has 78 employees as of September 2026.
Frontier Medicines has raised $256M in total, most recently a Series C round in June 2024.
Frontier Medicines was founded in 2018 by Daniel Nomura, Chris Varma.
Chris Varma (Co-Founder, Chairman & CEO) sits at the top of Frontier Medicines's reporting structure, with 6 direct reports.
The most common previous employers of current Frontier Medicines staff are Novartis (4 people), Broad Institute of MIT and Harvard (4 people), Pfizer (4 people).
Former Frontier Medicines employees most often move to Eli Lilly and Company (4), Septerna (3), Nurix Therapeutics (3).
Frontier Medicines attracts about 195 organic search visits a month, worth roughly $9K a month in equivalent ad spend.
The most common skills among Frontier Medicines staff are Drug Discovery, Molecular Biology, Biotechnology, Oncology, Research Skills.
Frontier Medicines staff are concentrated in Massachusetts, United States (21), California, United States (19), Greater Boston (11).
Frontier Medicines has about 30 people in Research, down 9% over the past year, as of September 2026.
Frontier Medicines has about 16 people in Business Development, up 14% over the past year, as of September 2026.
Computed from 59 current and 126 former Frontier Medicines profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.